Last reviewed · How we verify

NCT03602443

Feasibility of the Lee Silverman Voice Treatment®-BIG Intervention in Stroke

Completed NA Last updated 24 March 2020
What this trial tests

NA trial testing LSVT®BIG Intervention in Chronic Stroke in 5 participants. Completed in 31 December 2019.

Timeline
6 August 2018
Primary endpoint
31 December 2019
31 December 2019

Quick facts

Lead sponsorUniversity of Missouri-Columbia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment5
Start date6 August 2018
Primary completion31 December 2019
Estimated completion31 December 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Missouri-Columbia

Who can join

18 and older, any sex, with Chronic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate feasibility (acceptability, subject recruitment/retention, willingness to be randomized, and adherence rates) of delivering the Lee Silverman Voice Treatment®-BIG (LSVT®BIG) intervention with individuals with chronic stroke. Evaluate preliminary effect of the LSVT®BIG intervention on motor function and occupational performance with individuals with chronic stroke.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Chronic Stroke

Currently open trials in the same condition.

Other University of Missouri-Columbia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03602443.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing